What is the company's size? (Annual sales and employees)
Raa-Apex Acquisition LLC Dba Syrentis Clinical Research's annual revenues are $1 - $10 million (see exact revenue data)
What industry is the company in?
Raa-Apex Acquisition LLC Dba Syrentis Clinical Research is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.
Raa-Apex Acquisition LLC Dba Syrentis Clinical Research Annual Revenue and Growth Rate
Raa-Apex Acquisition LLC Dba Syrentis Clinical Research
Note: Raa-Apex Acquisition LLC Dba Syrentis Clinical Research's revenues are gauged from an analysis of company filings.
Raa-Apex Acquisition LLC Dba Syrentis Clinical Research's Income Statement (based on Industry Averages)
Raa-Apex Acquisition LLC Dba Syrentis Clinical Research P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Market Share of Raa-Apex Acquisition LLC Dba Syrentis Clinical Research's Largest Competitors
A competitive analysis shows these companies are in the same general field as Raa-Apex Acquisition LLC Dba Syrentis Clinical Research, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Raa-Apex Acquisition LLC Dba Syrentis Clinical Research.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Raa-Apex Acquisition LLC Dba Syrentis Clinical Research and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.